Recently, Wang and colleagues found that the miR-493-5p-dependent suppression of methyltransferase-like 3 (METTL3) increases the sensitivity of AML cells to the chemotherapeutic drug arabinocytosine [108]. This evidence concerns the gene METTL3 and acute myeloid leukemia.